TON - April 2013, Vol 6, No 3

If I had to grade my oncology nurses, I would give them, as a group, an A+. They have saved my life, cleaned my privates, kept me company, rejoiced with me when I was discharged, and consoled me with every wave or trickle of bad news I have faced during my care. Read More ›

I spent five years of my life being treated for cancer, but since then I’ve spent fifteen years being treated for nothing other than looking different than anyone else. Read More ›

In March, the National Compre-hensive Cancer Network (NCCN) guidelines for genetic/familial high-risk assessment for breast and ovarian cancers were updated. Read More ›

Many patients with multiple myeloma succumb to infection before they have a chance to benefit from cancer therapy, according to a new study from Sweden. Read More ›

Significant distress frequently accompanies the diagnosis and treatment of cancer but is often overlooked and is rarely screened for, according to Jimmie C. Holland, MD, of Memorial Sloan-Kettering Cancer Center, New York. Read More ›

In the February issue we published the article “Adherence to Therapy at Home: The Personal Touch.” This article, written by MMA, a woman undergoing treatment for cancer, addressed the idea that patients feel overwhelmed when they return home with “a bagful” of medications that they must incorporate into their daily life.

We asked our online reading community to let us know if this is a topic they address with their patients. The answer was a resounding yes. All respondents said they do talk to patients about adhering to their medication regimen at home. Respondents indicated that they provide information about how and when to take the medication for the best results.

Read More ›

Whereas survivorship should be viewed as another stage in the cancer journey—the same as diagnosis and treatment—concerns related to surviving cancer have been largely neglected. Read More ›

Conversations with terminally ill patients about treatment options for end-of-life care often occur when the patient is in pain, heavily medicated, and quite ill—on average, just 1 month before the patient dies. Read More ›

Extremely high levels of methotrexate can lead to precipitation of the drug in the renal tubules, delayed drug clearance, and the potential for acute renal failure. Read More ›

Page 1 of 2

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: